Skip to main content
. 2017 Nov 22;314(3):H508–H520. doi: 10.1152/ajpheart.00534.2017

Table 1.

Summary of intervention and cross-sectional studies that have administered sustained shear stress flow-mediated dilation and, where applicable, reactive hyperemia flow-mediated dilation

Artery Technique SS-FMD RH-FMD Reference
Intervention Arrows versus preintervention
    Prior antegrade shear stress Brachial Rhythmic handgrip 1
    l-NMMA and EDHF receptor inhibition Radial Hand heating 5, 8
    Angiotensin converting enzyme inhibitors in congestive heart failure Radial Hand heating 45
    l-NMMA and aspirin Radial Hand heating 60
    Endothelin type B receptor inhibition Radial Hand heating 6
    Anemia correction in end-stage renal disease Brachial Forearm heating 94
    Antioxidant Brachial Progressive handgrip 72
    Antioxidant or exercise training in the elderly Brachial Progressive handgrip 20
    Acute and chronic folic acid ingestion in the elderly Brachial Progressive handgrip 73
    l-NMMA Brachial Progressive handgrip 100
    l-NMMA in the elderly Brachial Progressive handgrip 93
    Ascorbic acid and l-NMMA in the elderly Brachial Progressive handgrip 92
    High-fat meal Brachial Rhythmic handgrip 62
    Altered contraction duty cycles Brachial Rhythmic handgrip 49
    Cold pressor test Brachial Rhythmic handgrip 83
    Acute mental stress Brachial Rhythmic handgrip 84
    Acute mental stress and cold pressor test Brachial Rhythmic handgrip 85
Cross-sectional Arrows versus healthy controls
    Uncomplicated type I diabetes Radial Hand heating 3
    Hypertension Radial Hand heating 7
    Autosomal dominant polycystic kidney disease Radial Hand heating 56
    End-stage renal disease Brachial Forearm heating 94
    Hypercholesterolemia Brachial Distal acetylcholine infusion 60
    Young smokers Brachial Rhythmic handgrip 25
    Obese young adults Brachial Rhythmic handgrip 81
    Systemic sclerosis Brachial Progressive handgrip 57

SS-FMD, sustained shear stress flow-mediated dilation; RH-FMD, reactive hyperemia flow-mediated dilation; l-NMMA, NG-monomethyl-l-arginine.